GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota

Ocular Oncology and Pathology
Christopher B ToomeyJonathan H Lin

Abstract

G protein mutations are common in uveal melanomas, and the vast majority target amino acid residue Q209 in either GNAQ or GNA11. The GNAQ R183Q mutation is found in a small fraction of uveal melanomas. We report a patient with an unusual presentation of uveal melanoma arising at an early age in the setting of congenital skin and ocular surface melanosis. A 34-year-old Hispanic female with congenital bilateral nevus of Ota and ocular surface melanosis presented with progressive loss of visual acuity and was found to have a juxtapapillary uveal melanoma. She was treated with brachytherapy, but the tumor relapsed. She underwent enucleation that revealed mixed spindle and epithelioid uveal melanoma cells with no extraocular or lymphovascular spread. Next-generation sequencing performed on DNA isolated from the enucleation specimen identified a GNAQ R183Q mutation and a PMS1 truncation mutation. Cytogenetic profiling revealed no monosomy 3. These findings raise the possibility that uveal melanomas bearing G protein R183 mutations may have distinct clinicopathologic profiles compared to those with Q209 mutations. Furthermore, this is the first reported case of a mutation in the mismatch repair gene PMS1 associated with uveal melanoma.

References

Jan 1, 1997·Human Mutation·N Papadopoulos, A Lindblom
Sep 27, 2003·Melanoma Research·Neil A CrossKaren Sisley
Dec 24, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Anette WeberAndrea Tannapfel
Dec 14, 2005·Archives of Ophthalmology·Mahmoud R HusseinGary S Wood
Aug 28, 2007·Ophthalmology·Bertil DamatoPeter Howard
Dec 17, 2008·Nature·Catherine D Van RaamsdonkBoris C Bastian
Apr 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Joachim H C OrthKlaus Aktories
Nov 6, 2010·Science·J William HarbourAnne M Bowcock
Nov 19, 2010·The New England Journal of Medicine·Catherine D Van RaamsdonkBoris C Bastian
Jan 2, 2013·Pathology·Rajmohan MuraliRichard A Scolyer
Jan 15, 2013·Nature Genetics·J William HarbourAnne M Bowcock
May 10, 2013·The New England Journal of Medicine·Matthew D ShirleyJonathan Pevsner
Mar 14, 2016·Trends in Molecular Medicine·Stephen K H Li, Alberto Martin
May 18, 2018·Scientific Reports·Nikola HajkovaIvana Ticha

❮ Previous
Next ❯

Citations

Aug 19, 2020·International Journal of Dermatology·Natalie M WilliamsKeyvan Nouri
Feb 8, 2020·Retina·Christopher B ToomeyJonathan H Lin
Jan 10, 2021·Pediatric Dermatology·Andrew R BlundellElena B Hawryluk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Catherine D Van RaamsdonkB C Bastian
Wiener klinische Wochenschrift
R GITTLER, N SEKIDO
British Journal of Cancer
A E KoopmansRotterdam Ocular Melanoma Study group
© 2021 Meta ULC. All rights reserved